Millennium Management
LTRN icon

Millennium Management’s Lantern Pharma LTRN Stock Holding History

Millennium Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,135
Closed -$47.3K – 6320
2024
Q2 		$47.3K Buy
+10,135
New +$60.9K ﹤0.01% 5425
2022
Q1 		– Sell
-48,558
Closed -$387K – 7234
2021
Q4 		$387K Buy
48,558
+35,870
+283% +$328K ﹤0.01% 5281
2021
Q3 		$142K Buy
+12,688
New +$164K ﹤0.01% 6271
2021
Q2 		– Sell
-42,106
Closed -$764K – 6849
2021
Q1 		$764K Buy
+42,106
New +$738K ﹤0.01% 4462

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management's LTRN Position: Q3 2024 in Review

Millennium Management sold out of Lantern Pharma (LTRN) in Q3 2024, closing a stake of 10,135 shares — an estimated $47.3K sold.

Millennium Management first reported a position in LTRN in Q1 2021 and held it in 4 quarters. The position peaked at $764K in Q1 2021. 31 funds tracked by Wall St. Rank hold LTRN as of Q3 2024.

  • Millennium Management reported no remaining Lantern Pharma position as of Q3 2024 after selling out during the quarter.
  • Millennium Management sold 10,135 Lantern Pharma shares in Q3 2024, an estimated $47.3K.
  • Millennium Management first reported a position in Lantern Pharma in Q1 2021 and held it in 4 quarters.
  • Millennium Management's Lantern Pharma position peaked at $764K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.